ES2171393T3 - Vacuna contra la serpulina hyodysenteriae. - Google Patents

Vacuna contra la serpulina hyodysenteriae.

Info

Publication number
ES2171393T3
ES2171393T3 ES92204010T ES92204010T ES2171393T3 ES 2171393 T3 ES2171393 T3 ES 2171393T3 ES 92204010 T ES92204010 T ES 92204010T ES 92204010 T ES92204010 T ES 92204010T ES 2171393 T3 ES2171393 T3 ES 2171393T3
Authority
ES
Spain
Prior art keywords
hemolysin
production
serpulina
serpuline
hydysenteriae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92204010T
Other languages
English (en)
Inventor
Huurne Agnes Ter
Susie Jane Muir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimminaco AG
Original Assignee
Dimminaco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimminaco AG filed Critical Dimminaco AG
Application granted granted Critical
Publication of ES2171393T3 publication Critical patent/ES2171393T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

DE ACUERDO CON LA INVENCION UNA VACUNA PUEDE PREPARARSE QUE CONTIENE UNA "SERPULINA HYODYSENTERIAE" MUTANTE QUE ES EFECTIVA EN SU PRODUCCION DE HEMOLISILINA BIOLOGICAMENTE ACTIVA. LA MUTACION POR LA QUE LA "SERPULINA HYODYSENTERIAE" SE VUELVE DEFECTUOSA EN SU PRODUCCION DE HEMOLISINA HEMOLITICAMENTE ACTIVA SE ESTABLECE POR MEDIO DE TECNICAS DE INGENIERIA GENETICA. TALES MUTACIONES COMPRENDEN POR EJEMPLO LA ELIMINACION DE PARTE O DEL GEN COMPLETO QUE CODIFICA LA HEMOLISINA Y/O LAS SECUENCIAS NUCLEOTIDAS QUE CONTROLAN LA PRODUCCION DE LA HEMOLISINA, O LA INSERCION DE UN NUCLEOTIDO O POLINUCLEOTIDO EXTRA QUE CODIFICA LA HEMOLISINA Y/O LAS SECUENCIAS NUCLEOTIDAS QUE CONTROLAN LA PRODUCCION DE LA HEMOLISINA, O UNA COMBINACION DE DICHAS ELIMINACION E INSERCION. ESTAS VACUNAS SON UTILES EN LA PREVENCION DE SERPULINA EN ANIMALES SUSCEPTIBLES TALES COMO EL CERDO.
ES92204010T 1991-12-23 1992-12-18 Vacuna contra la serpulina hyodysenteriae. Expired - Lifetime ES2171393T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91203384 1991-12-23

Publications (1)

Publication Number Publication Date
ES2171393T3 true ES2171393T3 (es) 2002-09-16

Family

ID=8208100

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92204010T Expired - Lifetime ES2171393T3 (es) 1991-12-23 1992-12-18 Vacuna contra la serpulina hyodysenteriae.

Country Status (12)

Country Link
US (1) US5882655A (es)
EP (1) EP0549066B1 (es)
JP (1) JPH05276936A (es)
KR (1) KR100292413B1 (es)
AT (1) ATE214424T1 (es)
AU (1) AU669343B2 (es)
CA (1) CA2085828A1 (es)
DE (1) DE69232479T2 (es)
DK (1) DK0549066T3 (es)
ES (1) ES2171393T3 (es)
PT (1) PT549066E (es)
ZA (1) ZA929876B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN631495A0 (en) 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(I)
US8337753B2 (en) 1998-05-01 2012-12-25 Gen-Probe Incorporated Temperature-controlled incubator having a receptacle mixing mechanism
DE10011529T1 (de) * 1998-05-01 2011-09-01 Gen-Probe Incorporated Automatisches Diagnoseanalysegerät und Verfahren
AR027791A1 (es) * 2000-04-12 2003-04-09 Hanley Peter O Proteinas de fusion con hemolisina, produccion y uso de las mismas
CA2743660A1 (en) * 2008-11-14 2010-05-20 Boehringer Ingelheim Vetmedica Gmbh Vaccine strains of brachyspira hyodysenteriae
WO2014096013A1 (en) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Novel recombinant outer membrane proteins from brachyspira hyodysenteriae and uses thereof
MX2018008415A (es) 2016-01-07 2018-12-10 Univ Gent Cepas de vacuna de brachyspira hyodysenteriae.
AU2018200954B2 (en) * 2017-03-23 2018-11-22 Australasian Pork Research Institute Ltd Live Vaccine Strains

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152415A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Method of increasing the effectiveness of oral vaccination for swine dysentery
US4203968A (en) * 1978-08-18 1980-05-20 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
GB8405530D0 (en) * 1984-03-02 1984-04-04 Lysons R J Vaccine for swine dysentery
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
US5281416A (en) * 1986-12-23 1994-01-25 Royal Melbourne Institute Of Technology Limited Swine dysentery vaccine
US5017478A (en) * 1987-07-16 1991-05-21 Berlex Laboratories, Inc. Transfected cells containing plasmids having genes oriented in opposing directions and methods of using
US5176910A (en) * 1989-01-17 1993-01-05 Ml Technology Ventures, L. P. Treponema hyodysenteriae hemolysin and uses therefor
IL103530A0 (en) * 1991-10-25 1993-03-15 Duphar Int Res Treponema hyodysenteriae vaccine
US5698394A (en) * 1994-06-01 1997-12-16 Board Of Regents Of The University Of Nebraska Nucleotide sequences and methods for detection of Serpulina hyodysenteriae
US7996197B1 (en) * 2002-09-12 2011-08-09 Sandia Corporation Clearance detector and method for motion and distance
KR101187756B1 (ko) * 2005-11-07 2012-10-08 엘지전자 주식회사 감시용 카메라의 프라이버시 마스크 표시 제어방법

Also Published As

Publication number Publication date
PT549066E (pt) 2002-08-30
US5882655A (en) 1999-03-16
ZA929876B (en) 1994-03-22
AU3038192A (en) 1993-06-24
CA2085828A1 (en) 1993-06-24
ATE214424T1 (de) 2002-03-15
AU669343B2 (en) 1996-06-06
EP0549066A1 (en) 1993-06-30
EP0549066B1 (en) 2002-03-13
JPH05276936A (ja) 1993-10-26
KR930013104A (ko) 1993-07-21
KR100292413B1 (ko) 2001-10-22
DK0549066T3 (da) 2002-05-21
DE69232479T2 (de) 2002-10-31
DE69232479D1 (de) 2002-04-18

Similar Documents

Publication Publication Date Title
DE3784907D1 (de) Oligosaccharide, immunogene und impstoffe und verfahren zur herstellung dieser oligosaccharide, immunogene und impstoffe.
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
IT1206311B (it) Agente terapeutico a base di oligonucleotide e metodi per laproduzione dello stesso.
HU911440D0 (en) Process for producing polypeptones
EP0500699A4 (en) Cross-protective salmonella vaccines
ES2171393T3 (es) Vacuna contra la serpulina hyodysenteriae.
DK216289D0 (da) Rekombinant - dna - afledte bordetella-toxinunderenheder og analoge deraf
ATE120487T1 (de) Therapeutische zusammensetzungen gegen streptokokken-infektionen, transformierte wirte, verfahren zur immunisierung und gentechnologisch hergestellte produkte.
JPS5585525A (en) Purified bacterial membranal proteoglycan* manufacture thereof and vaccine using it
HUT65598A (en) Method for preparation of vaccine against poultry coccidiosis
PT653489E (pt) Vacina contra a coccidiose em aves domesticas
BR9802361A (pt) Derivado imunogênico detoxificado de b-toxina de clostridium perfringens ou um seu fragmento imunogênico, sequência de nucleotìdeos compreendendo um fragmento de dna mutante, bactéria clostriduim perfringensm sistema de expressão baseado em uma bactéria gram-positiva, vacina para combater infecção de clostridium perfrigens, processo para a preparação de b-toxina nativa de clostridium perfrigens, e, processo para preparação de uma vacina para combater infecção de clostridium perfrigens.
DK0556333T3 (da) Avirulente Salmonella mikrober, der omfatter en mutation i cdt genet, og anvendelser deraf
IL97013A0 (en) Eimeria merozoite antigen,dna according it,the production of the antigen and its use as a vaccine
DK128490A (da) Renset gensekvens, som koder for protein ia, ib eller begge fra neisseria gonorrhoeae, rekombinantvektorer og organismer indeholdende sekvenser, dens fremstilling og anvendelse, neisseria-stamme og dennes paavisning
ATE310747T1 (de) Impfstoff gegen geflügelkokzidose
DE68916424D1 (de) Pasteurella-impfstoff.
MX9603876A (es) Procedimiento intermitente de digestion para producir pulpa deslignficada.
DK1350796T3 (da) Attenuerede gramnegative bakterier
MD126C2 (ro) Procedeu de obţinere 6-esterilor zaharozei

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 549066

Country of ref document: ES